WA startup funding remains subdued as national appetite slows
Techboard's quarterly report shows record national early-stage funding, driven by PEXA's sale and Airwallex's raise, while Western Australian funding stayed subdued, led by Respiron Pharmaceuticals, several ASX placements, grants and one acquisition.